Katy Askew

On the money: Mead Johnson sees "excellent progress" in China

By Katy Askew | 1 February 2013

Mead Johnson sees H2 recovery in China

Mead Johnson sees H2 recovery in China

US infant nutrition group Mead Johnson has highlighted "excellent progress" at its Chinese business in the back half of 2012 and after overcoming issues in the country in the first half of the year.

The company yesterday (31 January) booked a 7% jump in full-year sales, as a strong showing from its businesses in Latin America and China offset softer sales in the US and Europe. In China and Hong Kong, sales for the grew 5% to reach almost US$1.2bn, the company revealed.

Speaking during a conference call with analysts, Mead Johnson president and CEO Stephen Golsby was quick to emphasise a turnaround in the company's fortunes in the key Chinese market. During the first half, Mead had seen its market share eroded as it raised prices while a competitor offered aggressive promotions.

"While we fully acknowledge the first half challenge we faced in China, we made excellent progress in recovering market share in the second half, with further gains in the fourth quarter. And importantly, distributor inventories were restored to normal levels by year end," Golsby said.

While he was unwilling to "speculate" on whether there is likely to be another change in the promotional environment in the market, Golsby insisted Mead Johnson "is not seeing a significant worsening of that promotional environment between the last couple of quarters". He added: "We are certainly not driving it."

Rather than driving sales volumes through promotions, Golsby insisted the group preferred to build brand value. "We tend to prioritise equity building, advertising and activities. We believe that, that's ultimately what's going to drive our growth in China."

However, he added: "We are committed to defending our market share position and keeping price at a competitive level."

During 2012, Mead Johnson was able to realise single-digit price increases despite the highly price-sensitive environment, management revealed.

While the Chinese baby formula market is "certainly growing", expansion is at a "slower rate" than 2011, management revealed. This growth rate is expected to remain on a par during 2013, the group added.

Latin America is expected to be a significant growth engine during 2013 and in 2012 it delivered "the strongest growth among our regions," management indicated. Revenue from Latin America is "on track" to reach $1bn by 2015, the group added.

The market responded positively to Mead Johnson's results, with shares jumping 11.5% yesterday.

Sectors: Baby food, Emerging markets, Financials

Companies: Mead Johnson

View next/previous articles

Currently reading -

On the money: Mead Johnson sees "excellent progress" in China

There is currently 1 comment on this article

It should be interesting to see and hear from their COO and CFO at the CAGE Conference next month in London... and to compare MJN with Danone and Nestlé whose top management is also presenting. I shall be there for sure!

 

TheFoodAnalyst.com said at 3:52 pm, February 1, 2013

Reply to this comment

Related research

Global Baby Food and Formula Market 2012-2016

TechNavio's Analysts forecast the Global Baby Food and Formula market to grow at a CAGR of 5.4 percent over the period 2012-2016. One of the key factors contributing to this market growth is the growing urbanization especially in the developing count...

Nutraceuticals

The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. A six-year historic analysis is also...

Baby Foods and Infant Formula

This report analyzes the worldwide markets for Baby Foods and Infant Formula in US$ Million by the following Product Segments: Infant Formula (Baby Milks/Baby Formulas), Baby Meals, Baby Cereals, Baby Juices/Drinks, and Baby Biscuits/Cookies....

Related articles

In the spotlight: The uncertain fallout from China's infant formula probe

Chinese regulators have launched an anti-trust investigation into the infant formula sector in the country and under pressure from the authorities, multinational formula manufacturers have implemented a series of price cuts. But will the move address the structural issues facing the category? Katy Askew investigates.

US: Mead Johnson EBIT slips on investment

US infant formula market Mead Johnson has reported a dip in first-half operating profit, as higher investment levels offset improved sales and gross margins.

CHINA: Fonterra cuts maternal milk price amid formula probe

New Zealand dairy giant Fonterra will cut the price of a maternal health milk product in China, becoming the latest firm to respond to Beijing's investigation into prices in the sector.

Read further items in this columns

On the money

Food companies discuss and dissect their latest results.

Welcome to the home of food information, insight & intelligence

Not a member? Join here

Decrease font sizeDecrease font sizeDecrease font size Increase font sizeIncrease font sizeIncrease font size Comment on this article Email this to a friend Print this page